CEACAM5 and colorectal cancer: The growth-inhibitory effects of the HSP90 inhibitor onalespib were then assessed on the CEA-positive colorectal cancer cell lines (SNU1544, HT55, and LS174T), as they were considered most relevant for subsequent combination studies.